← Open Payments lookup

AGNES HEYL: Open Payments

NPI 1174540918 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$241 in 12 payments from 8 companies in 2025. Trend: 2023 $306 · 2024 $215 · 2025 $241

Food & beverage: $241
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$57
Teva Pharmaceuticals USA, Inc.2$37
Supernus Pharmaceuticals, Inc.2$34
Alkermes, Inc.1$27
E.R. Squibb & Sons, L.L.C.1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$23
Lundbeck LLC1$22
Axsome Therapeutics, Inc.1$17

Products named: UZEDY, ABILIFY MAINTENA, Qelbree, ARISTADA, COBENFY, CAPLYTA, ABILIFY ASIMTUFII, REXULTI.

Industry payments across MD — which companies pay providers there.